{"title":"一名急性髓性白血病患者的侵袭性真菌性鼻窦炎(Fusarium proliferatum/annulatum):病例报告和文献综述","authors":"Zeynep Cansu Caliskan , Gizem Karahan , Neslihan Koray , Yasin Gokcinar , Dolunay Gülmez , Sevtap Arikan-Akdagli , Serhat Unal , Omrum Uzun","doi":"10.1016/j.mycmed.2024.101461","DOIUrl":null,"url":null,"abstract":"<div><p><span>Antifungal prophylaxis with a mold-effective agent has led to a substantial decrease in invasive infections caused by </span><span><em>Aspergillus</em></span><span> spp. in the management of patients with acute myeloid leukemia<span> undergoing induction chemotherapy. However, difficult-to-treat infections caused by other molds, such as </span></span><span><span><em>Fusarium</em><em>, Lomentospora, and </em></span><em>Scedosporium</em></span><span> species may still complicate the neutropenic period. Here, we present a case of a 23-year-old woman with acute myeloid leukemia who developed a breakthrough invasive fungal rhinosinusitis caused by </span><em>Fusarium proliferatum/annulatum</em><span> on posaconazole<span> prophylaxis. The infection was diagnosed using clinical, microbiological, and radiological criteria and the isolate was identified using Matrix Assisted Lazer Desorption Ionization Time of Flight Mass Spectrometry (MALDI-TOF MS) and sequencing. We searched Pubmed with “</span></span><span><em>Fusarium proliferatum</em></span>”, “<em>Fusarium annulatum</em>”, “immunosuppression AND fusariosis“, “rhinosinusitis AND <em>Fusarium proliferatum</em><span>” and summarized the English literature for similar rhinosinusitis cases infected with the same pathogen.</span></p></div>","PeriodicalId":14824,"journal":{"name":"Journal de mycologie medicale","volume":null,"pages":null},"PeriodicalIF":2.2000,"publicationDate":"2024-01-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Invasive fungal rhinosinusitis by Fusarium proliferatum/annulatum in a patient with acute myeloid leukemia: A case report and review of the literature\",\"authors\":\"Zeynep Cansu Caliskan , Gizem Karahan , Neslihan Koray , Yasin Gokcinar , Dolunay Gülmez , Sevtap Arikan-Akdagli , Serhat Unal , Omrum Uzun\",\"doi\":\"10.1016/j.mycmed.2024.101461\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><p><span>Antifungal prophylaxis with a mold-effective agent has led to a substantial decrease in invasive infections caused by </span><span><em>Aspergillus</em></span><span> spp. in the management of patients with acute myeloid leukemia<span> undergoing induction chemotherapy. However, difficult-to-treat infections caused by other molds, such as </span></span><span><span><em>Fusarium</em><em>, Lomentospora, and </em></span><em>Scedosporium</em></span><span> species may still complicate the neutropenic period. Here, we present a case of a 23-year-old woman with acute myeloid leukemia who developed a breakthrough invasive fungal rhinosinusitis caused by </span><em>Fusarium proliferatum/annulatum</em><span> on posaconazole<span> prophylaxis. The infection was diagnosed using clinical, microbiological, and radiological criteria and the isolate was identified using Matrix Assisted Lazer Desorption Ionization Time of Flight Mass Spectrometry (MALDI-TOF MS) and sequencing. We searched Pubmed with “</span></span><span><em>Fusarium proliferatum</em></span>”, “<em>Fusarium annulatum</em>”, “immunosuppression AND fusariosis“, “rhinosinusitis AND <em>Fusarium proliferatum</em><span>” and summarized the English literature for similar rhinosinusitis cases infected with the same pathogen.</span></p></div>\",\"PeriodicalId\":14824,\"journal\":{\"name\":\"Journal de mycologie medicale\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":2.2000,\"publicationDate\":\"2024-01-27\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal de mycologie medicale\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1156523324000027\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"MYCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal de mycologie medicale","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1156523324000027","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"MYCOLOGY","Score":null,"Total":0}
Invasive fungal rhinosinusitis by Fusarium proliferatum/annulatum in a patient with acute myeloid leukemia: A case report and review of the literature
Antifungal prophylaxis with a mold-effective agent has led to a substantial decrease in invasive infections caused by Aspergillus spp. in the management of patients with acute myeloid leukemia undergoing induction chemotherapy. However, difficult-to-treat infections caused by other molds, such as Fusarium, Lomentospora, and Scedosporium species may still complicate the neutropenic period. Here, we present a case of a 23-year-old woman with acute myeloid leukemia who developed a breakthrough invasive fungal rhinosinusitis caused by Fusarium proliferatum/annulatum on posaconazole prophylaxis. The infection was diagnosed using clinical, microbiological, and radiological criteria and the isolate was identified using Matrix Assisted Lazer Desorption Ionization Time of Flight Mass Spectrometry (MALDI-TOF MS) and sequencing. We searched Pubmed with “Fusarium proliferatum”, “Fusarium annulatum”, “immunosuppression AND fusariosis“, “rhinosinusitis AND Fusarium proliferatum” and summarized the English literature for similar rhinosinusitis cases infected with the same pathogen.
期刊介绍:
The Journal de Mycologie Medicale / Journal of Medical Mycology (JMM) publishes in English works dealing with human and animal mycology. The subjects treated are focused in particular on clinical, diagnostic, epidemiological, immunological, medical, pathological, preventive or therapeutic aspects of mycoses. Also covered are basic aspects linked primarily with morphology (electronic and photonic microscopy), physiology, biochemistry, cellular and molecular biology, immunochemistry, genetics, taxonomy or phylogeny of pathogenic or opportunistic fungi and actinomycetes in humans or animals. Studies of natural products showing inhibitory activity against pathogenic fungi cannot be considered without chemical characterization and identification of the compounds responsible for the inhibitory activity.
JMM publishes (guest) editorials, original articles, reviews (and minireviews), case reports, technical notes, letters to the editor and information. Only clinical cases with real originality (new species, new clinical present action, new geographical localization, etc.), and fully documented (identification methods, results, etc.), will be considered.
Under no circumstances does the journal guarantee publication before the editorial board makes its final decision.
The journal is indexed in the main international databases and is accessible worldwide through the ScienceDirect and ClinicalKey platforms.